Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases that is thought to be caused by the activation and uncontrolled proliferation of T lymphocytes and macrophages, leading to widespread haemophagocytosis and cytokine overproduction. It is seen most commonly in systemic juvenile idiopathic arthritis, but is increasingly recognized also in juvenile systemic lupus erythematosus (J-SLE). Recognition of MAS in patients with J-SLE is often challenging because it may mimic the clinical features of the underlying disease or be confused with an infectious complication. This review summarizes the characteristics of patients with J-SLEassociated MAS reported in the literature or seen by the authors and analyses the distinctive clinical, diagnostic and therapeutic issues that the occurrence of MAS may raise in patients with J-SLE. Lupus (2007) 16, 587—592.
Sawhney S., Woo P., Murray KJMacrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child2001; 85: 421—426.
4.
Stéphan JL, Koné-Paut I., Galanbrun C., Mouy R., Bader-Meunier B., Prieur A-M.Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology2001; 40: 1285—1292.
5.
Ravelli A., Martini A.Macrophage activation syndrome. In Lehman TJA, Cimaz R eds. Pediatrics in systemic autoimmune diseases. Elsevier, 2007 (in press).
Grom AANatural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?Arthritis Rheum2004; 50: 689—698.
8.
Villanueva J. , Lee S., Giannini EH et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther2005; 7: R30—R37.
9.
Hadchouel M., Prieur AM, Griscelli C.Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drug or infection. J Pediatr1985; 106: 561—566.
10.
Janka G., Zur Stadt U.Familial and acquired hemophagocytic lymphohistiocytosis. Hematology (Am Soc Hematol Educ Program) 2005; 82—88.
11.
Athreya BHIs macrophage activation syndrome a new entity?Clin Exp Rheumatol2002; 20: 121—123.
12.
Ramanan AV, Schneider R.Macrophage activation syndrome — what's in a name!J Rheumatol2003; 30: 2513—2516.
13.
Ravelli A., Viola S., De Benedetti F., Magni-Manzoni S., Tzialla C., Martini A.Dramatic efficacy of cyclosporine A in macrophage activation syndrome. Clin Exp Rheumatol2000; 19: 108 (letter).
14.
Lambotte O. , Khellaf M., Harmouche H. et al. Characteristic and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome . Medicine2006; 85: 169—182.
15.
McCann LJ, Hasson N., Pilkington CAMacrophage activation syndrome as an early presentation of lupus. J Rheumatol2006; 33: 438—440 (letter).
16.
Avcin T., Tse S., Schneider R., Ngan B., Silverman E.Macrophage activation syndrome as the presenting manifestation of rheumatic disease in childhood. J Pediatr2006; 148: 683—686.
17.
Sterba G., Rodriguez C., Sifontes S., Vigilanza P.Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J Rheumatol2004; 31: 1014—1015.
18.
Muise A., Tallett SE, Silverman EDAre children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome?Pediatrics2003; 112: e495.
19.
Rigante D., Capoluongo E., Bertoni B. et al. First report of macrophage activation syndrome in hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum2007; 56: 658—661.
20.
Ravelli A., Magni-Manzoni S., Pistorio A. et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr2005; 146: 598—604.
21.
Mouy R., Stephan J-L., Pillet P., Haddad E., Hubert P., Prieur A-M.Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr1996; 129: 750—754.
22.
Ravelli A., De Benedetti F., Viola S., Martini A.Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr1996; 28: 275—278.
23.
Morales PM, Jimenez Bfj, Yanes P., Rios D., Godinez R.Bone marrow with reactive histiocytosis, hemophagocytosis and storage histiocytes in systemic lupus erythematosus. Arthritis Rheum1992; 35(Suppl): S239 (abstract).
24.
Ravelli A., Viola S., De Benedetti F., Magni Manzoni S, Martini A.Visceral leishmaniasis as a cause of unexplained fever and cytopenia in systemic lupus erythematosus. Acta Paediatr2002; 91: 246—247 (letter).
